Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV): Complete Statistical AnalysisIndependent statistical analysis of Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00845650).
- Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants: Complete Statistical AnalysisIndependent statistical analysis of Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants: primary endpoint results, effect estimate with confidence…
- Safety and Pharmacology Study of VP 20629 in Adults With Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments: Complete Statistical AnalysisIndependent statistical analysis of Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn: Complete Statistical AnalysisIndependent statistical analysis of Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals’ IPV Vaccine (PoliorixTM) in Toddlers: Complete Statistical AnalysisIndependent statistical analysis of Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Artificial Tears in Dry Eye Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Artificial Tears in Dry Eye Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00932477).
- Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability of PF-06649751 in Parkinson’s Disease Patients With Motor Fluctuations: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557333).
- Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Seroguard Use: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Seroguard Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03640559).
- Safety and Tolerability of Soy Fiber: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Soy Fiber: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04499482).
- Safety and Tolerability of Vortioxetine (LuAA21004) – Open Label Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia: primary endpoint…
- Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability Study of N6022 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of N6022 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147406).
- Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Tolerability Study of SHP626 in Overweight and Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of SHP626 in Overweight and Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00593606).
- Safety Evaluation of a Q-fever Vaccine, NDBR 105: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of a Q-fever Vaccine, NDBR 105: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00584454).
- Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01708213).
- Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…